by mariel | Oct 16, 2025 | Portfolio News
Veradermics closed an oversubscribed $150 million Series C financing led by SR One to fund Phase 3/registrational work for its lead program. by mariel | Oct 8, 2025 | Portfolio News
Zenas announced a license agreement for global development/commercialization rights to orelabrutinib for MS and additional autoimmune assets; Phase 3 activity in progressive MS was underway/initiating. by mariel | Oct 1, 2025 | Portfolio News
Somatus reported results from a new study showing a statistically significant reduction in mortality for kidney disease patients, reinforcing outcomes from its care model. by mariel | Sep 17, 2025 | Portfolio News
Roche entered into a definitive merger agreement to acquire 89bio, including $14.50/share cash at closing plus a contingent value right tied to milestones. by mariel | Sep 11, 2025 | Portfolio News
Kestra reported ~$19M revenue in Q1 FY26 (+52% YoY), improved gross margin, and increased FY26 revenue guidance to $88M. by mariel | Sep 8, 2025 | Portfolio News
Mirum announced completion of enrollment in the Phase 2b VISTAS study of volixibat in PSC cholestatic pruritus; topline data expected in 2Q 2026.